Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Pronounced Polymorphic Eruption of Pregnancy in a Primipara.

Schmidgen MI, Weidenthaler-Barth B, Steinbrink K.

Dtsch Arztebl Int. 2019 Sep 20;116(38):644. doi: 10.3238/arztebl.2019.0644. No abstract available.

2.

Melatonin exerts oncostatic capacity and decreases melanogenesis in human MNT-1 melanoma cells.

Kleszczyński K, Kim TK, Bilska B, Sarna M, Mokrzynski K, Stegemann A, Pyza E, Reiter RJ, Steinbrink K, Böhm M, Slominski AT.

J Pineal Res. 2019 Sep 18:e12610. doi: 10.1111/jpi.12610. [Epub ahead of print]

PMID:
31532834
3.

Pruritus in Autoimmune and Inflammatory Dermatoses.

Zeidler C, Pereira MP, Huet F, Misery L, Steinbrink K, Ständer S.

Front Immunol. 2019 Jun 21;10:1303. doi: 10.3389/fimmu.2019.01303. eCollection 2019. Review.

4.

Intervention of Inflammatory Monocyte Activity Limits Dermal Fibrosis.

Haub J, Roehrig N, Uhrin P, Schabbauer G, Eulberg D, Melchior F, Shahneh F, Probst HC, Becker C, Steinbrink K, Raker VK.

J Invest Dermatol. 2019 Oct;139(10):2144-2153. doi: 10.1016/j.jid.2019.04.006. Epub 2019 Apr 27.

PMID:
31039360
5.

Neue Therapieansätze für entzündliche und bullöse Formen kongenitaler Ichthyosen: erste klinische Erfahrungen.

Süßmuth K, Metze D, Ullrich N, Hausser I, Fischer J, Steinbrink K, Traupe H, Oji V.

J Dtsch Dermatol Ges. 2019 May;17 Suppl 2:12-15. doi: 10.1111/ddg.13782. No abstract available.

PMID:
31037846
6.

Tiefes, ulzerierendes Granuloma anulare mit resultierender Funktionsstörung des Ellenbogen-Gelenks.

Langer E, Weidenthaler-Barth B, Hötker A, Steinbrink K.

J Dtsch Dermatol Ges. 2019 Apr;17(4):445-447. doi: 10.1111/ddg.13800_g. German. No abstract available.

PMID:
30958941
7.

Deep ulcerating granuloma annulare resulting in impaired function of the elbow.

Langer E, Weidenthaler-Barth B, Hötker A, Steinbrink K.

J Dtsch Dermatol Ges. 2019 Apr;17(4):446-447. doi: 10.1111/ddg.13800. Epub 2019 Mar 1. No abstract available.

PMID:
30821415
8.

Blasenbildung an den Händen nach Maniküre in einem Nagelstudio.

Langer E, Weidenthaler-Barth B, Steinbrink K.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1058-1060. doi: 10.1111/ddg.13590_g. No abstract available.

PMID:
30117710
9.

Blistering of the hands following a manicure at a nail salon.

Langer E, Weidenthaler-Barth B, Steinbrink K.

J Dtsch Dermatol Ges. 2018 Aug;16(8):1058-1060. doi: 10.1111/ddg.13590. Epub 2018 Jul 11. No abstract available.

PMID:
29998527
10.

Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona.

Tonigold M, Simon J, Estupiñán D, Kokkinopoulou M, Reinholz J, Kintzel U, Kaltbeitzel A, Renz P, Domogalla MP, Steinbrink K, Lieberwirth I, Crespy D, Landfester K, Mailänder V.

Nat Nanotechnol. 2018 Sep;13(9):862-869. doi: 10.1038/s41565-018-0171-6. Epub 2018 Jun 18.

PMID:
29915272
11.

Dietary wheat amylase trypsin inhibitors exacerbate murine allergic airway inflammation.

Zevallos VF, Raker VK, Maxeiner J, Scholtes P, Steinbrink K, Schuppan D.

Eur J Nutr. 2019 Jun;58(4):1507-1514. doi: 10.1007/s00394-018-1681-6. Epub 2018 Mar 29.

PMID:
29600329
12.

Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.

Domogalla MP, Rostan PV, Raker VK, Steinbrink K.

Front Immunol. 2017 Dec 11;8:1764. doi: 10.3389/fimmu.2017.01764. eCollection 2017. Review.

13.

Chemoselective Dual Labeling of Native and Recombinant Proteins.

Agrawalla BK, Wang T, Riegger A, Domogalla MP, Steinbrink K, Dörfler T, Chen X, Boldt F, Lamla M, Michaelis J, Kuan SL, Weil T.

Bioconjug Chem. 2018 Jan 17;29(1):29-34. doi: 10.1021/acs.bioconjchem.7b00675. Epub 2017 Dec 20.

14.

Allergen-Specific Low Zone Tolerance Is Independent of MRP8/14-, TLR4-, TLR7-, and TLR9-Mediated Immune Processes.

Schmidt T, Lorenz N, Raker VK, Schmidgen MI, Mahnke K, Enk A, Roth J, Steinbrink K.

J Invest Dermatol. 2018 Feb;138(2):452-455. doi: 10.1016/j.jid.2017.09.020. Epub 2017 Sep 22. No abstract available.

15.

Regulatory T cell deficient scurfy mice exhibit a Th2/M2-like inflammatory response in the skin.

Haeberle S, Raker V, Haub J, Kim YO, Weng SY, Yilmaz OK, Enk A, Steinbrink K, Schuppan D, Hadaschik EN.

J Dermatol Sci. 2017 Sep;87(3):285-291. doi: 10.1016/j.jdermsci.2017.07.001. Epub 2017 Jul 13.

PMID:
28811075
16.

Pembrolizumab-induzierter Lichen planus pemphigoides bei einem Patienten mit metastasiertem Melanom.

Schmidgen MI, Butsch F, Schadmand-Fischer S, Steinbrink K, Grabbe S, Weidenthaler-Barth B, Loquai C.

J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272_g. No abstract available.

PMID:
28677196
17.

Early inflammatory players in cutanous fibrosis.

Raker V, Haub J, Stojanovic A, Cerwenka A, Schuppan D, Steinbrink K.

J Dermatol Sci. 2017 Sep;87(3):228-235. doi: 10.1016/j.jdermsci.2017.06.009. Epub 2017 Jun 15. Review.

PMID:
28655471
18.

Pembrolizumab-induced lichen planus pemphigoides in a patient with metastatic melanoma.

Schmidgen MI, Butsch F, Schadmand-Fischer S, Steinbrink K, Grabbe S, Weidenthaler-Barth B, Loquai C.

J Dtsch Dermatol Ges. 2017 Jul;15(7):742-745. doi: 10.1111/ddg.13272. Epub 2017 Jun 16. No abstract available.

PMID:
28622432
19.

Europäische Leitlinien (S1) für die Anwendung von hochdosierten intravenösen Immunglobulinen in der Dermatologie.

Enk A, Hadaschik E, Eming R, Fierlbeck G, French L, Girolomoni G, Hertl M, Jolles S, Karpati S, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D.

J Dtsch Dermatol Ges. 2017 Feb;15(2):227-238. doi: 10.1111/ddg.13013_g.

PMID:
28214313
20.

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.

Enk A, Hadaschik E, Eming R, Fierlbeck G, French L, Girolomoni G, Hertl M, Jolles S, Karpati S, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D.

J Dtsch Dermatol Ges. 2017 Feb;15(2):228-241. doi: 10.1111/ddg.13013. Epub 2016 Dec 30.

PMID:
28036140
21.

Nutritional Wheat Amylase-Trypsin Inhibitors Promote Intestinal Inflammation via Activation of Myeloid Cells.

Zevallos VF, Raker V, Tenzer S, Jimenez-Calvente C, Ashfaq-Khan M, Rüssel N, Pickert G, Schild H, Steinbrink K, Schuppan D.

Gastroenterology. 2017 Apr;152(5):1100-1113.e12. doi: 10.1053/j.gastro.2016.12.006. Epub 2016 Dec 16.

PMID:
27993525
22.

Myeloid cell populations and fibrogenic parameters in bleomycin- and HOCl-induced fibrosis.

Raker VK, Ook KY, Haub J, Lorenz N, Schmidt T, Stegemann A, Böhm M, Schuppan D, Steinbrink K.

Exp Dermatol. 2016 Nov;25(11):887-894. doi: 10.1111/exd.13124.

PMID:
27307019
23.

Down-Regulation of CD62L Shedding in T Cells by CD39+ Regulatory T Cells Leads to Defective Sensitization in Contact Hypersensitivity Reactions.

Mahnke K, Useliene J, Ring S, Kage P, Jendrossek V, Robson SC, Bylaite-Bucinskiene M, Steinbrink K, Enk AH.

J Invest Dermatol. 2017 Jan;137(1):106-114. doi: 10.1016/j.jid.2016.08.023. Epub 2016 Sep 10.

24.

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology.

Enk AH, Hadaschik EN, Eming R, Fierlbeck G, French LE, Girolomoni G, Hertl M, Jolles S, Karpati S, Steinbrink K, Stingl G, Volc-Platzer B, Zillikens D.

J Eur Acad Dermatol Venereol. 2016 Oct;30(10):1657-1669. doi: 10.1111/jdv.13725. Epub 2016 Jul 13.

25.

Interleukin-2 Functionalized Nanocapsules for T Cell-Based Immunotherapy.

Frick SU, Domogalla MP, Baier G, Wurm FR, Mailänder V, Landfester K, Steinbrink K.

ACS Nano. 2016 Oct 25;10(10):9216-9226. doi: 10.1021/acsnano.5b07973. Epub 2016 Oct 12.

PMID:
27723299
26.

IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic Activity.

Kryczanowsky F, Raker V, Graulich E, Domogalla MP, Steinbrink K.

J Immunol. 2016 Nov 1;197(9):3607-3617. Epub 2016 Sep 28.

27.

Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.

Tuettenberg A, Steinbrink K, Schuppan D.

Nanomedicine (Lond). 2016 Oct;11(20):2735-2751. Epub 2016 Sep 23. Review.

PMID:
27658725
28.

Pillars Article: Induction of Tolerance by IL-10-Treated Dendritic Cells. J. Immunol. 1997. 159: 4772-4780.

Steinbrink K, Wölfl M, Jonuleit H, Knop J, Enk AH.

J Immunol. 2016 Sep 1;197(5):1547-55. No abstract available.

29.

Epicutaneous and Oral Low-Zone Tolerance Protects from Colitis in Mice.

Schmidt T, Lorenz N, Raker V, Reißig S, Waisman A, Weigmann B, Steinbrink K.

J Invest Dermatol. 2016 Sep;136(9):1831-1839. doi: 10.1016/j.jid.2016.04.037. Epub 2016 May 17. Review.

30.

The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases.

Raker VK, Becker C, Steinbrink K.

Front Immunol. 2016 Mar 31;7:123. doi: 10.3389/fimmu.2016.00123. eCollection 2016. Review.

31.

Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man.

Raker VK, Domogalla MP, Steinbrink K.

Front Immunol. 2015 Nov 9;6:569. doi: 10.3389/fimmu.2015.00569. eCollection 2015. Review.

32.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients.

Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N; German Network for Systemic Scleroderma.

J Rheumatol. 2016 Jan;43(1):66-74. doi: 10.3899/jrheum.150382. Epub 2015 Nov 15.

33.

[Sarcoidosis : Organ involvement, diagnosis, current treatment].

Weidenthaler-Barth B, Steinbrink K, Kümmel A, von Stebut E.

Hautarzt. 2015 Jul;66(7):549-63. doi: 10.1007/s00105-015-3646-5. German.

PMID:
26077943
34.

Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization.

Lelle M, Frick SU, Steinbrink K, Peneva K.

J Pept Sci. 2014 May;20(5):323-33. doi: 10.1002/psc.2617. Epub 2014 Feb 19.

PMID:
24677287
35.

Research in practice: the impact of interferon-α therapy on immune tolerance.

Raker V, Steinbrink K.

J Dtsch Dermatol Ges. 2014 Apr;12(4):315-9. doi: 10.1111/ddg.12297. Epub 2014 Mar 14. Review.

36.

Interferon α interferes with immunological tolerance.

Becker C, Bopp T, Steinbrink K.

Oncoimmunology. 2013 Dec 1;2(12):e27528. Epub 2014 Jan 3.

37.

Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.

Rudolph BM, Loquai C, Gerwe A, Bacher N, Steinbrink K, Grabbe S, Tuettenberg A.

Exp Dermatol. 2014 Mar;23(3):202-4. doi: 10.1111/exd.12336.

PMID:
24495013
38.

Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.

Heylmann D, Bauer M, Becker H, van Gool S, Bacher N, Steinbrink K, Kaina B.

PLoS One. 2013 Dec 23;8(12):e83384. doi: 10.1371/journal.pone.0083384. eCollection 2013.

39.

Interferon-α suppresses cAMP to disarm human regulatory T cells.

Bacher N, Raker V, Hofmann C, Graulich E, Schwenk M, Baumgrass R, Bopp T, Zechner U, Merten L, Becker C, Steinbrink K.

Cancer Res. 2013 Sep 15;73(18):5647-56. doi: 10.1158/0008-5472.CAN-12-3788. Epub 2013 Jul 22.

40.

Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells.

Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H.

Front Immunol. 2013 Apr 3;4:82. doi: 10.3389/fimmu.2013.00082. eCollection 2013.

41.

Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.

Hofmann C, Scheurer S, Rost K, Graulich E, Jamin A, Foetisch K, Saloga J, Vieths S, Steinbrink K, Adler HS.

J Allergy Clin Immunol. 2013 May;131(5):1384-92.e6. doi: 10.1016/j.jaci.2012.10.037. Epub 2012 Dec 11.

PMID:
23246018
42.

Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4+ T cell activation.

Frick SU, Bacher N, Baier G, Mailänder V, Landfester K, Steinbrink K.

Macromol Biosci. 2012 Dec;12(12):1637-47. doi: 10.1002/mabi.201200223. Epub 2012 Oct 5.

PMID:
23042770
43.

IL-2 Expression in Activated Human Memory FOXP3(+) Cells Critically Depends on the Cellular Levels of FOXP3 as Well as of Four Transcription Factors of  T Cell Activation.

Bendfeldt H, Benary M, Scheel T, Steinbrink K, Radbruch A, Herzel H, Baumgrass R.

Front Immunol. 2012 Aug 27;3:264. doi: 10.3389/fimmu.2012.00264. eCollection 2012.

44.

Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance.

Luckey U, Schmidt T, Pfender N, Romer M, Lorenz N, Martin SF, Bopp T, Schmitt E, Nikolaev A, Yogev N, Waisman A, Jakob T, Steinbrink K.

J Allergy Clin Immunol. 2012 Sep;130(3):781-797.e11. doi: 10.1016/j.jaci.2012.06.022.

PMID:
22935591
45.

Diagnostics of autoimmune bullous diseases in German dermatology departments.

van Beek N, Knuth-Rehr D, Altmeyer P, Assaf C, Babilas P, Bayerl C, Benoit S, Dippel E, Effendy I, Eming R, Fischer M, Glaenz T, Gläser R, Goebeler M, Gollnick H, Götze S, Gross G, Hadaschik E, Herbst R, Hermes B, Homey B, Hunzelmann N, Jünger M, Kapp A, Kern JS, Körber A, Luger T, Mechtel D, Megahed M, Moll I, Peters KP, Pfeiffer C, Ring J, Röcken M, Sárdy M, Seitz CS, Stadler R, Steinbrink K, Sticherling M, Szeimies RM, Tronnier M, Ulrich J, Vogt T, Wagner N, Welzel J, Wenzel J, Wozel G, Zouboulis CC, Zillikens D, Schmidt E.

J Dtsch Dermatol Ges. 2012 Jul;10(7):492-9. doi: 10.1111/j.1610-0387.2011.07840.x. Epub 2012 Feb 3. English, German.

PMID:
22304433
46.

T cell killing by tolerogenic dendritic cells protects mice from allergy.

Luckey U, Maurer M, Schmidt T, Lorenz N, Seebach B, Metz M, Steinbrink K.

J Clin Invest. 2011 Oct;121(10):3860-71. doi: 10.1172/JCI45963. Epub 2011 Sep 1.

47.

Interferon-α abrogates tolerance induction by human tolerogenic dendritic cells.

Bacher N, Graulich E, Jonuleit H, Grabbe S, Steinbrink K.

PLoS One. 2011;6(7):e22763. doi: 10.1371/journal.pone.0022763. Epub 2011 Jul 27.

48.

Immune regulation by dendritic cells and T cells--basic science, diagnostic, and clinical application.

Tuettenberg A, Becker C, Correll A, Steinbrink K, Jonuleit H.

Clin Lab. 2011;57(1-2):1-12. Review.

PMID:
21391459
49.

Toxic dermatitis in patients treated with Taxotere (docetaxel): three case reports.

von Stebut E, Steinbrink K.

Int J Clin Pharmacol Ther. 2011 Jan;49(1):1-2. No abstract available.

PMID:
21176718
50.

[Erythematosus plaques and nodules in a 50-year old patient with rheumatoid arthritis. Interstitial granulomatous dermatitis with arthritis].

Rietz S, Möhler T, Bräuninger W, Steinbrink K.

J Dtsch Dermatol Ges. 2011 Jan;9(1):67-9. doi: 10.1111/j.1610-0387.2010.07534.x. German. No abstract available.

PMID:
21166781

Supplemental Content

Loading ...
Support Center